10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities.
Anavex Life Sciences Corp. (AVXL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 490,600 | $5,269,044 | -1% | 0.01% |
| 2. | 372,500 | $4,000,650 | +40% | 0% | |
| 3. | 371,400 | $3,988,836 | 0.05% | ||
| 4. | Sculptor Capital Daniel S. Och | 370,100 | $3,974,874 | -1% | 0.05% |
| 5. | Citadel Investment Group Ken Griffin | 240,906 | $2,587,330 | +844% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.64 | 2,835 | Director | 5,000 | 2024-06-14 | Filing | |
| $4.52 | 5,000 | Director | 5,000 | 2024-05-15 | Filing | |
| $10.93 | 1,000 | Director | 2,165 | 2021-05-17 | Filing | |
| $12.97 | 165 | Director | 1,165 | 2021-02-19 | Filing | |
| $12.62 | 1,000 | Director | 1,000 | 2021-02-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.11 | 73,380 | Officer, Director | 1,250,210 | 2024-03-28 | Filing | |
| $7.98 | 268,000 | Officer, Director | 1,018,210 | 2023-06-28 | Filing | |
| $9.06 | 50,000 | Director | 1,306,458 | 2022-05-25 | Filing | |
| $26.00 | 51,620 | Officer, Director | 1,018,210 | 2021-06-29 | Filing | |
| $26.53 | 166,696 | Officer | 22,963 | 2021-06-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,703,623 | $57,517,085 | 0% | |
| 2. | 1,000,351 | $8,583,009 | 0.74% | |
| 3. | 546,626 | $4,690,051 | 0% | |
| 4. | 223,131 | $1,914,467 | 0% | |
| 5. | 214,725 | $1,842,341 | 0.01% |
News See All
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript
Clint Tomlinson: Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for today's call.
Jim Cramer’s Lightning Rounds: 9 Stocks in Focus
Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock market's expectations for...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript
Operator: Good morning. And welcome to the Anavex Life Sciences Fiscal 2024 Second Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for today’s call.
12 $10 Stocks That Will Triple
According to JPMorgan, the global outlook for securities markets in 2024 suggests a more positive scenario compared to the previous year, with expectations of easing inflation and interest rates.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14.
These 5 Stocks Under $10 Are Poised To Explode
Spire Global, Inc. (NYSE:SPIR) is one of the cheap stocks under $10 for anyone eyeing exposure in the industrial sector. Spire Global, Inc.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Anavex Life Sciences Fiscal 2023 Fourth Quarter Conference Call. My name is Clint Tomlinson and I will be your host for today's call.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Anavex Life Sciences Fiscal 2023 Fourth Quarter Conference Call. My name is Clint Tomlinson and I will be your host for today's call.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.